Ardelyx (ARDX) Cash & Equivalents (2013 - 2026)
Ardelyx's Cash & Equivalents was $46.32 million in Q3 2026, up 8.4% from $42.72 million a year earlier but down 52.3% from the prior quarter.
Powered by 
Analysis
Ardelyx (ARDX) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Ardelyx came in at $68 million, up 4.7% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $64.93 million in FY2024 (+202.4%), $21.47 million in FY2023 (-77.7%), $96.14 million in FY2022 (+32.7%) and $72.43 million in FY2021 (-20.4%).
- Quarterly Cash & Equivalents has moved between $21.47 million (Q4 2023) and $97.19 million (Q2 2026) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for four straight quarters, with growth averaging 39.4% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2024 (growth of 202.4%); the worst was Q4 2023 (a decline of 77.7%).
- Per Business Quant data, ARDX's Cash & Equivalents in the three quarters before Q3 2026 was $97.19 million (Q2 2026), $31.21 million (Q1 2026) and $68 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Ardelyx | 755.60 Mn | -314.33 Mn | 123.12 Mn | 46.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 46.32 Mn |
| Jun 30, 2026 | 97.19 Mn |
| Mar 31, 2026 | 31.21 Mn |
| Dec 31, 2025 | 68.00 Mn |
| Sep 30, 2025 | 42.72 Mn |
| Jun 30, 2025 | 90.05 Mn |
| Mar 31, 2025 | 30.81 Mn |
| Dec 31, 2024 | 64.93 Mn |
| Sep 30, 2024 | 47.43 Mn |
| Jun 30, 2024 | 41.89 Mn |
| Mar 31, 2024 | 36.15 Mn |
| Dec 31, 2023 | 21.47 Mn |
| Sep 30, 2023 | 33.77 Mn |
| Jun 30, 2023 | 30.06 Mn |
| Mar 31, 2023 | 92.49 Mn |
| Dec 31, 2022 | 96.14 Mn |
| Sep 30, 2022 | 61.63 Mn |
| Jun 30, 2022 | 53.41 Mn |
| Mar 31, 2022 | 47.08 Mn |
| Dec 31, 2021 | 72.43 Mn |
API Access
Ardelyx Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ARDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();